- 1892-22-42-Piperidinone,3-amino-
- 189224-26-82-Propenoic acid,3-[4-(1H-imidazol-1-ylmethyl)phenyl]-, sodium salt (1:1), (2E)-
- 189224-48-41H-Imidazole,2-(2-ethyl-2,3-dihydro-2-benzofuranyl)-
- 1892-29-1Ethanol,2,2'-dithiobis-
- 1892-31-5Propanethioicacid (9CI)
- 18923-62-1Zincate(1-),trichloro-, hydrogen (8CI,9CI)
- 18923-92-7Erbium,tris(1,1,1,5,5,5-hexafluoro-2,4-pentanedionato-O,O')-, hydrate, (OC-6-11)-(9CI)
- 18924-67-9Ethanol,2,2'-(hexadecylimino)bis-
- 1892-54-23-Phenanthrylamine
- 1892-57-51,3-Propanediamine,N3-(ethylcarbonimidoyl)-N1,N1-dimethyl-
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
| Name |
N-(4-(((2,4-Diamino-5-methyl-6-quinazo-linyl)methyl)amino)benzoyl)-L-aspartic acid |
EINECS | N/A |
| CAS No. | 18921-70-5 | Density | 1.3696 (rough estimate) |
| PSA | 193.55000 | LogP | 2.99870 |
| Solubility | N/A | Melting Point |
270°C (rough estimate) |
| Formula | C21H22 N6 O5 | Boiling Point | 550.3°C (rough estimate) |
| Molecular Weight | 438.443 | Flash Point | N/A |
| Transport Information | N/A | Appearance | N/A |
| Safety | Poison by subcutaneous and intraperitoneal routes. Human mutation data reported. When heated to decomposition it emits toxic fumes of NOx. | Risk Codes | N/A |
| Molecular Structure |
|
Hazard Symbols | N/A |
| Synonyms |
Asparticacid, N-[p-[[(2,4-diamino-5-methyl-6-quinazolinyl)methyl]amino]benzoyl]-, L-(8CI); NSC 122870; SK 29836 |
N-(4-(((2,4-Diamino-5-methyl-6-quinazo-linyl)methyl)amino)benzoyl)-L-aspartic acid Chemical Properties
IUPAC Name: 2-[[4-[(2,4-diamino-5-methylquinazolin-6-yl)methylamino]benzoyl]amino]butanedioic acid
Synonyms of N-(4-(((2,4-Diamino-5-methyl-6-quinazo-linyl)methyl)amino)benzoyl)-L-aspartic acid (CAS NO.18921-70-5): BRN 0905365 ; Methasquin ; N-(p-(((2,4-Diamino-5-methyl-6-quinazolinyl)methyl)amino)benzoyl)-L-aspartic acid ; NSC 122870 ; SK 29836 ; Aspartic acid, N-(p-(((2,4-diamino-5-methyl-6-quinazolinyl)methyl)amino) benzoyl)-, L- (8CI) ; Aspartic acid, N-(p-(((2,4-diamino-5-methyl-6-quinazolinyl)methyl)amino)benzoyl)-, L- ; L-Aspartic acid, N-(4-(((2,4-diamino-5-methyl-6-quinazolinyl)methyl)amino) benzoyl)-, (9CI) ; L-Aspartic acid, N-(4-(((2,4-diamino-5-methyl-6-quinazolinyl)methyl)amino)benzoyl)- (9CI)
CAS NO: 18921-70-5
Molecular Formula of N-(4-(((2,4-Diamino-5-methyl-6-quinazo-linyl)methyl)amino)benzoyl)-L-aspartic acid (CAS NO.18921-70-5): C21H22N6O5
Molecular Weight: 438.4366
H bond acceptors: 11
H bond donors: 8
Freely Rotating Bonds: 8
Polar Surface Area: 108.41 ?2
Index of Refraction: 1.749
Molar Refractivity: 118.28 cm3
Molar Volume: 290.4 cm3
Surface Tension: 89.3 dyne/cm
Density of N-(4-(((2,4-Diamino-5-methyl-6-quinazo-linyl)methyl)amino)benzoyl)-L-aspartic acid (CAS NO.18921-70-5): 1.509 g/cm3
Molecular Structure:
.png)
N-(4-(((2,4-Diamino-5-methyl-6-quinazo-linyl)methyl)amino)benzoyl)-L-aspartic acid Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| mouse | LD50 | intraperitoneal | 50110ug/kg (50.11mg/kg) | National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. Vol. JAN1986, | |
| mouse | LD50 | subcutaneous | 158mg/kg (158mg/kg) | National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. Vol. JAN1986, |
N-(4-(((2,4-Diamino-5-methyl-6-quinazo-linyl)methyl)amino)benzoyl)-L-aspartic acid Safety Profile
Poison by subcutaneous and intraperitoneal routes. Human mutation data reported. When heated to decomposition it emits toxic fumes of NOx.
What can I do for you?
Get Best Price
